Relapse isn't failure. It's a signal. Is your software still listening after discharge?

Every treatment center pours enormous energy into 30, 60, and 90 days of care. Then the client walks out the door, and the attention drops off. That drop-off, more than the treatment episode itself, is where long-term recovery is decided.

Relapse is a clinical signal, not a verdict

Between 40% and 60% of people treated for a substance use disorder return to use within a year. That rate is comparable to relapse in hypertension (50 to 70%) and asthma (McLellan et al., JAMA, 2000). The National Institute on Drug Abuse is explicit that relapse is not a failure of treatment. It is a signal that care should be adjusted, resumed, or intensified. NIDA's own Drugs, Brains, and Behavior monograph makes the same point: a return to use should trigger a change in the treatment plan, not a discharge summary that reads like a final grade. A signal only helps if someone is listening.

The scale of unmet need makes the handoff even more urgent

The gap between people who need treatment and people who receive it is large and has not closed. In 2025, an estimated 47.2 million people age 12 or older needed substance use treatment, and only 7.6 million, or 16.0%, received it, leaving 39.6 million, or 84.0%, without care, according to SAMHSA's 2025 National Survey on Drug Use and Health. Every discharged client an organization loses track of is a person re-entering a system that is already stretched thin, instead of stepping down or up within a program that already knows their history.

The picture is not all bleak. Among adults who considered themselves to have had a substance use problem, 22.3 million, or 73.0%, said they were in recovery or had recovered, per SAMHSA's 2025 companion report on adult recovery. Recovery is common. It is also frequently nonlinear, which is exactly why the post-discharge period deserves the same operational rigor as intake.

What completion data actually shows

SAMHSA's Treatment Episode Data Set (TEDS) is the closest thing the field has to a national scoreboard, and it is worth reading carefully. In the 2024 TEDS report, 614,138 discharges, or 47.8% of discharges with valid disposition data, were recorded as completions (SAMHSA, 2024 TEDS Annual Report). Just under half. The rest were transfers, administrative discharges, or clients lost to follow-up, categories that get flattened together far too often in internal reporting.

TEDS also tracks substance use at the point of discharge, not just at admission. Among 2024 discharges, 68.8% reported substance use at admission compared with 57.4% at discharge. Use went down, meaningfully, but it did not disappear for most clients. That is consistent with a chronic condition, not a cure, and it is why TEDS treats retention, abstinence, housing stability, employment, criminal justice involvement, and social support as outcome measures in their own right, rather than reducing everything to a single completion flag (SAMHSA TEDS methodology).

The handoff is where people are lost

The most dangerous moment in the continuum is the transition out of acute care. Only about 23% of detox admissions ever transition to ongoing treatment, and clients who receive follow-up care within 14 days of discharge are significantly less likely to be readmitted (Journal of Substance Abuse Treatment, 2020). The window is narrow, and it closes fast.

SAMHSA's 2025 survey data adds a related point: among people with past-year SUD, 97.3% of those who received withdrawal management services also received substance use treatment, and 92.4% of those who received peer support or recovery coaching also received treatment. Detox and peer support are not standalone events. They function as on-ramps, and they only work as on-ramps if someone is tracking whether the client actually merges onto the next lane.

Continuing care works when it is actually delivered

This is not a counsel of despair. A meta-analysis of 19 randomized trials found that continuing care produces a small but significant improvement in outcomes, with longer and more active programs performing best (McKay et al., J. Subst. Abuse Treat., 2014). Quarterly Recovery Management Checkups, a structured form of re-engagement, got people back into treatment sooner and reduced time spent using (Scott & Dennis, Addiction, 2009).

Most software cannot see the person after discharge

The operational problem is basic. Treatment software is built around the inpatient episode. Alumni management, if it exists at all, is a bolt-on, often a separate app entirely. The category has been consolidating around exactly this gap, and one major EMR recently acquired a standalone alumni app to fill it. When the clinical record, the CRM, and the alumni tool are three disconnected systems, a discharged client falls into the space between them, and the relapse signal arrives too late, or never.

The clinical record is not the problem here. It does its job during the stay. The problem is the absence of a connective layer that follows the person: one continuous thread from first contact through discharge to alumni, so a missed check-in or a readmission is visible while there is still time to act.

What a real post-discharge operating model tracks

A useful continuity model captures specific data points, not vague intentions to "stay in touch":

• Scheduled follow-up before discharge: appointment date, receiving provider, level of care, transportation plan, medication access, and a consented communication plan.
• Early outreach: documented contact attempts in the first several days after discharge, the window when a missed appointment, a medication lapse, or renewed use first becomes visible.
• Risk-triggered re-engagement: rapid reassessment after a missed visit, a self-reported use, an overdose, a crisis contact, or a loss of recovery support.
• Closed-loop referrals: confirmation that the receiving clinician or program actually accepted the referral, not just that a referral form was faxed.
• Longitudinal outcomes: retention, abstinence or reduced use, overdose events, housing, employment, and connection to peer support, mirroring the categories SAMHSA already uses in TEDS.

What belongs on the executive dashboard

Admissions, operations, and revenue leaders need numbers that go beyond a completion percentage:

• Percentage of discharges with a scheduled follow-up appointment.
• Percentage with confirmed receiving-provider acceptance.
• Contact rate at 3, 7, 14, and 30 days.
• Follow-up attendance rate and medication-continuity rate where indicated.
• Re-engagement rate after a missed appointment or reported return to use.
• Thirty, 90, and 180-day retention or re-entry rates.
• Discharges broken out by disposition, including transfer, completion, administrative discharge, and lost to follow-up.
• Denial and authorization-delay rates by payer and level of care.
• Time to first post-discharge contact, caseload, and open appointment supply.

Documentation matters for compliance as much as for clinical quality. A return to use should trigger reassessment and a modified care plan, not an automatic discharge coded as a failed treatment. That distinction affects medical necessity documentation, payer conversations, and internal quality improvement alike. Coverage changes, benefit exhaustion, and gaps between levels of care can interrupt treatment even when clinical need is unchanged, so authorization status deserves the same follow-up attention as clinical status. Post-discharge outreach also has to respect applicable confidentiality rules for substance use records, which is a reason this work needs a designed workflow rather than an informal habit of a case manager texting old clients.

The real benchmark

Relapse will always be part of the disease. The real benchmark is not simply whether a patient completed treatment. It is whether the organization detected renewed risk or use, reconnected the person to care, and documented the resulting clinical action. That is a different question than the one most discharge paperwork answers, and it is the one that determines whether a center's alumni are a mailing list or an actual continuity of care.